ARCHIVES

Talbot, Schein Ask Weickar for 41.3 Billion for NCI

This article is from The Cancer Letter archive.

Vol. 09 No. 18 | May 6, 1983

Download PDF Visit The Full Archive

Related Articles

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

NCCS Networker Volume 1 Issue 2, Summer 1987

June 13, 1987

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer

August 30, 2013

ASCO, FDA Website To Help Demystify Expanded Access

June 25, 2010

Velcade Improves Survival In Relapsed Multiple Myeloma

July 29, 2005